Abstract: A diffuser includes a baffle having an air inlet end, an air outlet end and an outwardly tapering wall extending between the air inlet end and the air outlet end, and which defines a diffusing air chamber, and a grille connected to the baffle, the grille including a plurality of air outlets. The air inlet end of the baffle includes an air inlet and a drainage channel, spaced from the air inlet, for receiving water which has entered the air chamber through the air outlets. The drainage channel has drainage holes for draining water away from the air inlet.

Abstract: The disclosures herein relate to novel compounds of formula wherein Ar1 and R1 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.

Abstract: A hand dryer comprising a jetting nozzle comprising a duct in fluid communication with a slot which forms a nozzle outlet, and a blower which blows air through the jetting nozzle to produce an air jet. The jetting nozzle is configured such that the angle of inclination of the air jet with respect to a direction which is perpendicular to the longitudinal direction of the slot varies in the longitudinal direction of the slot.

Abstract: A diffuser includes an air inlet for receiving an airflow from a hair dryer, a grille having a plurality of air outlets for emitting at least part of the airflow from the diffuser, a baffle having an outwardly tapering wall which defines a diffusing air chamber through which the airflow passes between the air inlet and the air outlets, and an external wall which surrounds the wall of the baffle to define a second air chamber therebetween. The second air chamber has a plurality of ports in fluid communication with the ambient atmosphere.

Abstract: A diffuser includes an air inlet for receiving an airflow from a hair dryer, an external grille having a plurality of air outlets for emitting at least part of the airflow from the diffuser, and an internal grille located between the air inlet and the external grille.

Abstract: The disclosures herein relate to novel compounds of formula wherein Ar1 and R1 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.

Abstract: Methods for preventing, inhibiting or treating parasitic flatworm infection in a vertebrate are provided that include administering an effective amount of a composition comprising one or more ergot alkaloids, one or more lysergic acid amides, or one or more dimethoxyisoquinoline derivatives

Abstract: The disclosures herein relate to novel compounds of formula wherein R1, R2, R3 and R4 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.

Abstract: The disclosures herein relate to novel compounds of formula wherein R1, R2 and R3 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.

Abstract: A device that creates visible light in space comprises of a light source and optics system that result in irradiated visible spectrum light rays with a low intensity such that the light is not visible by the normal observer. Multiple rays of visible-spectrum low-intensity non-visible light intersect. When the constructive intensity of the intersecting light is above the threshold for being visible then light appears at that place. The light rays to and from the visible light remain non-visible. The addition of irradiated visible light results in additional visual effects. The visible light can be moved in space, and form multi-dimensional images and holograms. User and programmable controls, with communication abilities and data storage, can mediate the light source and optics to control the visible image.

Abstract: The disclosures herein relate to novel compounds of formula wherein R1, R2, R3 and R4 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.

Abstract: A device that creates visible light in space comprises of a light source and optics system that result in irradiated visible spectrum light rays with a low intensity such that the light is not visible by the normal observer. Multiple rays of visible-spectrum low-intensity non-visible light intersect. When the constructive intensity of the intersecting light is above the threshold for being visible then light appears at that place. The light rays to and from the visible light remain non-visible. The addition of irradiated visible light results in additional visual effects. The visible light can be moved in space, and form multi-dimensional images and holograms. User and programmable controls, with communication abilities and data storage, can mediate the light source and optics to control the visible image.

Abstract: The disclosures herein relate to novel compounds of formula wherein R1, R2 and R3 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.

Abstract: According to the invention there is provided a compound of formula A1 which may be useful in the treatment of a condition or disorder ameliorated by the inhibition of the A1-A21, or, particularly, the A2, receptor wherein the compound of formula A1 has the structure, wherein, A represents Cy1 or HetA; Cy1 represents a 5- to 14-membered aromatic, fully saturated or partially unsaturated carbocylic ring system comprising one, two or three rings, which Cy1 group is optionally substituted by one or more R4a substituents; HetA represents a 5- to 14-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one, two or three rings and which HetA group is optionally substituted by one or more R4b substituents; B represents a Cy2 or HetB; Cy2 represents a 3- to 10-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one or two rings, whic

Abstract: A hand dryer comprising a first jetting nozzle comprising a first duct in fluid communication with a first slot which forms a first nozzle outlet and a second jetting nozzle, disposed opposite the first jetting nozzle, comprising a second duct in fluid communication with a second slot which forms a second nozzle outlet. The first and second slots extend transversely with respect to the hand dryer. At least a portion of each of the first and second slots is curved such that the distance between the slots varies in the longitudinal direction of at least one of the slots. The hand dryer further comprises a blower which blows air through the jetting nozzles to produce respective air jets.

Abstract: The disclosures herein relate to novel compounds of formula wherein Ar1 and R1 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.

Abstract: The disclosures herein relate to novel compounds of formula wherein Ar1 and R1 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.